Therapeutic potential of antigen receptor-engineered regulatory T cells for immunotherapy of autoimmune diseases

被引：0
|
作者：
Pohar, Jelka [1 ,2 ]
O'Connor, Richard [3 ]
Manfroi, Benoit [1 ]
El-Behi, Mohamed [1 ]
Jouneau, Luc [4 ]
Boudinot, Pierre [4 ]
Bunse, Mario [5 ]
Uckert, Wolfgang [5 ]
Luka, Marine [6 ,7 ]
Menager, Mickael [6 ,7 ]
Liblau, Roland [8 ]
Anderton, Stephen M.
Fillatreau, Simon [1 ,9 ,10 ]
机构：
[1] Ctr Natl Rech Sci CNRS, Inst Necker Enfants Malades, Inst Natl Sante & Rech Med INSERM U1151, UMR 8253, Paris, France
[2] Natl Inst Biol, Ljubljana, Slovenia
[3] Univ Edinburgh, Edinburgh, Scotland
[4] Univ Paris Saclay, INRAE, UVSQ, VIM, Jouy En Josas, France
[5] Helmholtz Assoc, Max Delbruck Ctr Mol Med, Berlin, Germany
[6] Univ Paris, Imagine Inst, Lab Inflammatory Responses & Transcript Networks, Atip Avenir Team, Paris, France
[7] Imagine Inst, Labtech Single Cell Imagine, Paris, France
[8] Univ Toulouse III, Infin Inst Toulousain Malad Infect & Inflammatoir, Toulouse, France
[9] Univ Paris, Fac Med, Paris, France
[10] Hop Necker Enfants Malad, AP HP, Paris, France
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
53
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [1] Chimeric antigen receptor-engineered regulatory T lymphocytes: promise for immunotherapy of autoimmune disease
    Li Yi
    Yin Weifan
    Yang Huan
    [J]. CYTOTHERAPY, 2019, 21 (09) : 925 - 934
  • [2] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
    Cartellieri, Marc
    Bachmann, Michael
    Feldmann, Anja
    Bippes, Claudia
    Stamova, Slava
    Wehner, Rebekka
    Temme, Achim
    Schmitz, Marc
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
  • [3] A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
    Zhang, Erhao
    Xu, Hanmei
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10 : 1 - 11
  • [4] Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Acute Myeloid Leukemia
    Cartellieri, Marc
    Michalk, Irene
    von Bonin, Malte
    Krueger, Thomas
    Stamova, Slava
    Koristka, Stefanie
    Arndt, Claudia
    Feldmann, Anja
    Schmitz, Marc
    Wermke, Martin
    Lindemann, Dirk
    Bornhaeuser, Martin
    Ehninger, Gerhard
    Bachmann, Michael
    [J]. BLOOD, 2011, 118 (21) : 1124 - 1125
  • [5] A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
    Erhao Zhang
    Hanmei Xu
    [J]. Journal of Hematology & Oncology, 10
  • [6] Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
    Ethan Q Han
    Xiu-ling Li
    Chun-rong Wang
    Tian-fang Li
    Shuang-yin Han
    [J]. Journal of Hematology & Oncology, 6
  • [7] Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
    Han, Ethan Q.
    Li, Xiu-ling
    Wang, Chun-rong
    Li, Tian-fang
    Han, Shuang-yin
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [8] T cell receptor-engineered T cells for leukemia immunotherapy
    Zhang, Yikai
    Li, Yangqiu
    [J]. CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [9] T cell receptor-engineered T cells for leukemia immunotherapy
    Yikai Zhang
    Yangqiu Li
    [J]. Cancer Cell International, 19
  • [10] Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
    Wang, Xiao
    Yang, Xuejiao
    Yuan, Xiang
    Wang, Wenbo
    Wang, Yueying
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)
12345